The Early Diagnosis and Warning Role of Erectile Dysfunction
NCT ID: NCT01249703
Last Updated: 2010-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150000 participants
OBSERVATIONAL
2008-01-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Study the warning role of ED in some diseases.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Provide signed informed consent.
3. Have a history of erectile dysfunction (ED: defined as a consistent change in the quality of erection that adversely affects the subject's satisfaction with sexual intercourse) .
4. Have a stable monogamous relationship with a female partner. To some subjects with poor sexual experience, re-evaluation would be conducted after a 4-weeks sex education.
5. Make at least four sexual intercourse attempts with the female sexual study partner during the 4-week therapeutic period without medication.
6. Agree not to use any other ED treatment for at least 4 weeks.
Exclusion Criteria
2. Had clinically noteworthy penile deformities, pelvic surgery or trauma of perineal region;
3. Had received long-term pharmacotherapy (including antioxidant agents, vitamins and traditional Chinese drugs).
4. An addiction problem (with a history of injection or administration of opium, poppy, heroin, hemp, morphine, cocaine, caffeine, ketamine and meperidine etc.)
18 Years
80 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chunhua Deng, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chunhua Deng, MD, PhD
Role: primary
Yanping Huang, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Chunhua Deng
Identifier Type: -
Identifier Source: org_study_id